Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Korean Medical Science ; : 112-113, 2003.
Artículo en Inglés | WPRIM | ID: wpr-63343

RESUMEN

We report an unbalanced translocation involving chromosome 2 and 7 due to a balanced reciprocal translocation 2;7 in the father. The female fetus had a partial trisomy of the long arm of chromosome 2 with a partial monosomy of distal 7q. Ultrasound at the first trimester had indicated normal fetal anatomy, including normal intracranial structures. Parental karyotypes showed a paternal balanced translocation: 46,XY,t(2;7)(q37.3;->q34). The unbalanced translocation in the fetus resulted in trisomy for 2q37.3 qter and monosomy for 7q34->qter. Postnatal examination showed that the female abortus had a cleft lip and palate, and mild dysmorphic features. The clinical phenotype was in agreement with previous descriptions and allowed us to propose a fetal phenotype for this chromosomal abnormality.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Embarazo , Anomalías Múltiples/embriología , Anomalías Múltiples/genética , Aborto Habitual/genética , Aborto Terapéutico , Trastornos de los Cromosomas/embriología , Trastornos de los Cromosomas/genética , Cromosomas Humanos Par 2/ultraestructura , Cromosomas Humanos Par 7/ultraestructura , Enfermedades Fetales/genética , Enfermedades Fetales/patología , Feto/anomalías , Monosomía , Fenotipo , Translocación Genética , Trisomía
2.
Korean Journal of Obstetrics and Gynecology ; : 1236-1240, 2002.
Artículo en Coreano | WPRIM | ID: wpr-87498

RESUMEN

Tamoxifen, which is often used in breast cancer therapy, has also been used in the treatment of patients with advanced and recurrent endometrial carcinoma. Tamoxifen has been shown to have significant benificial effects in the treatment of breast cancer patients as hormonal therapy. However, there is evidence that tamoxifen may affect other hormone sensitive organs, including the uterus and ovaries. An increased risk of endometrial polyps, endometrial hyperplasia and endometrial cancer has been reported in tamoxifen treated women. We are able to make this report because we have experienced uterine endometrial carcinosarcoma which is developed in a patient treated with tamoxifen for five years following a modified radical mastectomy due to breast cancer in our hospital.


Asunto(s)
Femenino , Humanos , Neoplasias de la Mama , Mama , Carcinosarcoma , Hiperplasia Endometrial , Neoplasias Endometriales , Endometrio , Mastectomía Radical Modificada , Ovario , Pólipos , Tamoxifeno , Útero
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA